NO20004331L - Fluoxetinhydroklorid for Õ dempe hetetokter - Google Patents

Fluoxetinhydroklorid for Õ dempe hetetokter

Info

Publication number
NO20004331L
NO20004331L NO20004331A NO20004331A NO20004331L NO 20004331 L NO20004331 L NO 20004331L NO 20004331 A NO20004331 A NO 20004331A NO 20004331 A NO20004331 A NO 20004331A NO 20004331 L NO20004331 L NO 20004331L
Authority
NO
Norway
Prior art keywords
hot flashes
woman
fluoxetine hydrochloride
fluoxetine
cushion hot
Prior art date
Application number
NO20004331A
Other languages
English (en)
Other versions
NO20004331D0 (no
Inventor
Iii Hunter Heath
Jr Leo Plouffe
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO20004331L publication Critical patent/NO20004331L/no
Publication of NO20004331D0 publication Critical patent/NO20004331D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Foreliggende oppfinnelse omfatter en fremgangsmåte for å dempe hetetokter hos en. kvinne ved å administrere fluoxetin til denne kvinnen. Et annet aspekt ved oppfinnelsen er en fremgangsmåte for å dempe hetetokter hos en kvinne som gjennomgår raloxifen-administrering ved å administrere fluoxetin til denne kvinnen. Et annet aspekt ved oppfinnelsen er en farmasøytisk formulering omfattende fluoxetin og raloxifen.
NO20004331A 1998-03-02 2000-08-31 Fluoxetinhydroklorid for Õ dempe hetetokter NO20004331D0 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7654198P 1998-03-02 1998-03-02
US11657099P 1999-01-21 1999-01-21
PCT/US1999/003827 WO1999044601A1 (en) 1998-03-02 1999-02-22 Fluoxetine hydrochloride for decreasing hot flashes

Publications (2)

Publication Number Publication Date
NO20004331L true NO20004331L (no) 2000-08-31
NO20004331D0 NO20004331D0 (no) 2000-08-31

Family

ID=26758223

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004331A NO20004331D0 (no) 1998-03-02 2000-08-31 Fluoxetinhydroklorid for Õ dempe hetetokter

Country Status (15)

Country Link
EP (1) EP0943329A1 (no)
JP (1) JP2002505280A (no)
KR (1) KR20010015918A (no)
CN (1) CN1291889A (no)
AU (1) AU3306399A (no)
BR (1) BR9908431A (no)
CA (1) CA2321648A1 (no)
EA (1) EA200000890A1 (no)
HU (1) HUP0101404A3 (no)
IL (1) IL138084A0 (no)
NO (1) NO20004331D0 (no)
PL (1) PL342883A1 (no)
SK (1) SK12982000A3 (no)
TR (1) TR200002507T2 (no)
WO (1) WO1999044601A1 (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6498184B2 (en) 2000-12-05 2002-12-24 Akzo Nobel N.V. Serotonergic compound for a method of treatment of hot flushes in post-menopausal women
EP1213017A3 (en) * 2000-12-05 2003-11-12 Akzo Nobel N.V. Use of a 5-HT2C receptor agonist for the treatment of hot flushes
JP2004525940A (ja) * 2001-03-29 2004-08-26 イーライ・リリー・アンド・カンパニー 火照りの処置のためのデュロキセチン
DE60303040T2 (de) 2002-07-24 2006-08-03 Eli Lilly And Co., Indianapolis Dihydro-dibenzo[b,e]oxepin-basierte, selektive oestrogen-rezeptor modulatoren, zusammensetzungen und methoden
DE60310591T2 (de) 2002-07-24 2007-09-27 Eli Lilly And Co., Indianapolis Pentacyclische oxepine und derivate davon, verfahren zu deren herstellung und pharmazeutische zusammensetzungen, die diese enthalten
US7345096B2 (en) 2002-10-15 2008-03-18 Wyeth Use of norepinephrine reuptake modulators for preventing and treating vasomotor symptoms
US7524846B2 (en) 2003-10-14 2009-04-28 Wyeth Arylalkyl- and cycloalkylalkyl-piperazine derivatives and methods of their use
US7531543B2 (en) 2003-10-14 2009-05-12 Wyeth Phenylpiperazine cycloalkanol derivatives and methods of their use
US7491723B2 (en) 2003-10-14 2009-02-17 Wyeth Alkanol and cycloalkanol-amine derivatives and methods of their use
US7419980B2 (en) 2003-10-14 2008-09-02 Wyeth Fused-aryl and heteroaryl derivatives and methods of their use
US7402698B2 (en) 2003-10-14 2008-07-22 Wyeth Secondary amino-and cycloamino-cycloalkanol derivatives and methods of their use
US7365076B2 (en) 2003-10-14 2008-04-29 Wyeth Substituted aryl cycloalkanol derivatives and methods of their use
US7550485B2 (en) 2003-10-14 2009-06-23 Wyeth Substituted N-heterocycle derivatives and methods of their use
US7414052B2 (en) 2004-03-30 2008-08-19 Wyeth Phenylaminopropanol derivatives and methods of their use
US7517899B2 (en) 2004-03-30 2009-04-14 Wyeth Phenylaminopropanol derivatives and methods of their use
JP2009502798A (ja) * 2005-07-21 2009-01-29 ワイス 神経系障害および状態の処置方法
WO2007041258A1 (en) 2005-09-29 2007-04-12 Wyeth Benzothiadiazolyphenylalkylamine derivatives for use in the treatment of conditions ameliorated by monoamine reuptake
WO2007041257A2 (en) 2005-09-29 2007-04-12 Wyeth Substituted propylamine derivatives and methods of their use
US20080033050A1 (en) 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine
WO2017130209A1 (en) * 2016-01-29 2017-08-03 Hyder Pottoo Faheem Novel drug combination for treatment of generalised seizures and/or generalised seizures with associated neurological disorders.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5534526A (en) * 1993-12-21 1996-07-09 Eli Lilly And Company Methods for inhibiting vasomotor symptoms and attending psychological disturbances surrounding post-menopausal syndrome

Also Published As

Publication number Publication date
TR200002507T2 (tr) 2000-12-21
HUP0101404A2 (hu) 2001-10-28
JP2002505280A (ja) 2002-02-19
AU3306399A (en) 1999-09-20
WO1999044601A1 (en) 1999-09-10
HUP0101404A3 (en) 2002-09-30
KR20010015918A (ko) 2001-02-26
CA2321648A1 (en) 1999-09-10
EA200000890A1 (ru) 2001-02-26
PL342883A1 (en) 2001-07-16
EP0943329A1 (en) 1999-09-22
SK12982000A3 (sk) 2001-04-09
BR9908431A (pt) 2000-10-31
IL138084A0 (en) 2001-10-31
CN1291889A (zh) 2001-04-18
NO20004331D0 (no) 2000-08-31

Similar Documents

Publication Publication Date Title
NO20004331L (no) Fluoxetinhydroklorid for Õ dempe hetetokter
ES2305003T3 (es) Uso de antagonistas de estrogenos y agonistas de estrogenos en condiciones patologicas de inhibicion.
NO950774L (no) Fremgangsmåte for inhibering av bentap og nedsettelse av serumkolesterol
BR9006924A (pt) Formulacao para tratamento de sintomas e doencas,uso de formulacao para o tratamento de sintomas e doencas,metodo para o tratamento de sintomas e doencas,distribuicao de agentes medicinais e terapeuticos para o tratamento de sintomas e doencas e combinacao para administracao em mamiferos
GT200100055A (es) Una composicion farmaceutica para el tratamiento del dolor agudo, cronico y/o el dolor neuropatico y las migrañas.
MY121276A (en) Use of glp-1 or analogs to abolish catabolic changes after surgery
NO980592L (no) Nye opioidpeptider
NO20015931L (no) Farmasöytiske formuleringer og fremgangsmåter som omfatter intranasal morfin
AR012304A1 (es) Composiciones y metodos para el tratamiento de enfermedades intestinales inflamatorias y el uso de dicha composicion para preparar medicamentos paradichos tratamientos.
GB9917822D0 (en) Nmda antagonist
ITRM910922A1 (it) Composizione farmaceutica anticefalalgica per somministrazione endonasale, procedimento per prepararla e suo impiego terapeutico
BR0117198A (pt) Método de indução de ovulação usando um modulador do nìvel de camp de não-polipeptìdeo
BR0112661A (pt) Nova combinação de agonista (5ht2) e antagonista (5ht6) da serotonina como formulação farmacêutica
BR0313388A (pt) Método para tratar, remediar ou evitar a psorìase em um paciente, uso de um composto de antagonista de cgrp, composição farmacêutica para tratamento da psorìase, e, método para identificar um composto candidato para o uso em um medicamento para tratar a psorìase
NO20000293L (no) Preparater, kits og fremgangsmõter for inhibering av cerebrale neurovaskulære forstyrrelser og muskulære hodepiner
ATE292453T1 (de) Antivirale arznei
NO20024646D0 (no) Kombinasjonsterapier med vaskul¶r-skadende aktivitet
DK1063995T3 (da) Kombination til behandling af alkoholafhængighed indeholdende en opiod-antagonist og en NMDA-receptorkompleks-modulator
HRP20030024A2 (en) Method for the treatment of climacteric disorders in women or after the menopause
DK0946162T3 (da) Anvendelse af p-aminophenol-derivater til fremstilling af farmaceutiske præparater, som er nyttige til behandlingen af neurodegenerative sygdomme
YU42397A (sh) Korišćenje raloksifena za pripremu leka
NO975581L (no) Fremgangsmåte for å redusere bentap
BR0109753A (pt) Combinação farmacêutica, formulação farmacêutica, conjunto de partes, método para tratamento profilático ou terapêutico de um paciente que sofre de, ou é suscetìvel a, aterosclerose, e, usos de uma formulação, de uma combinação, ou de um conjunto de partes
AR066455A2 (es) Uso de compuestos n-metil-n-[(1r)-1-fenil-2-(3r)-3-hidroxipirrolidin -1-il-=-etil]-2,2-difenilacetamida para producir un medicamento para el tratamiento de emfermedades intestinales no inflamatorias
NO984446L (no) FremgangsmÕte for behandling av smerte

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application